Published in AIDS Weekly, May 29th, 2000
Patient recruitment will begin immediately for the trial, which was conceived by a team of scientists headed by Luis J. Montaner, DVM, DPhil, an assistant professor at The Wistar Institute, and will be overseen by clinicians in the University of Pennsylvania Health System.
Current state-of-the-art therapy for HIV infection is to administer a cocktail of three drugs that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.